Approval · Notice of Compliance 7554 · 2005
ZELNORM: Notice of Compliance 7554
Issued October 20, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7554
- Date
- October 20, 2005
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication for chronic idiopathic constipation
- Therapeutic class
- 5-ht4 receptor partial agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZELNORM | Not yet assigned | — |
Medicinal ingredients
- TEGASEROD 6 MG per TAB